Home
News
About
Company profile
Company culture
Company honor
Orgaization
Branch
Company history
Company staff
Products
Gynecology
Respiratory system
Hormones
Antipyretic analgesic
Spiritual
Antiviral
Antibacterial
Oral anesthetics
Urology
Masks
Water-electrolyte balance
Digestive system
Cardiovascular
Pieces
Nutrition and Metabolism
API
Service
Service concept
Bid Information
Contact
用药常识
女性健康
感冒预防
高血压防治
疼痛防治
家庭保健
儿童健康
心脑血管
The company invested in the acquisition of "Bengbu Fengyuan Pharmaceutical Technology Development Co., Ltd."
In April 2012, the company invested in the acquisition of "Bengbu Fengyuan Pharmaceutical Technology Development Co., Ltd.", integrated research and development resources, and improved research and development capabilities.
2021
08-06
The company released a report on the issuance of non-public shares and a listing announcement, raising about 300 million yuan
In March 2012, the company released a report on the issuance of non-public shares and a listing announcement, raising about 300 million yuan.
The company's enterprise technology center was recognized as an enterprise technology center by five ministries and commissions
In November 2012, the company's enterprise technology center was recognized as an enterprise technology center by five ministries and commissions.
Fengyuan Pharmaceutical won the "2010-2011 Excellent Practice Unit of Chinese Enterprise Information Construction"
In April 2011, Fengyuan Pharmaceutical was awarded the "2010-2011 Excellent Practice Unit of Chinese Enterprise Informatization Construction".
"Anhui Fengyuan Bengbu Pharmaceutical Co., Ltd." was established.
In January 2011, "Anhui Fengyuan Bengbu Pharmaceutical Co., Ltd." was established.
Build a production base for raw materials such as paracetamol and cephalosporins
In November 2010, Bengbu Bayi Pharmaceutical Co., Ltd. was acquired, and "Anhui Fengyuan Likang Pharmaceutical Co., Ltd." was established on its basis to build a production base for raw materials such as paracetamol and cephalosporins.
The company cooperates with Hefei University of Technology
In October 2010, the company cooperated with Hefei University of Technology to set up the "Fengyuan Pharmaceutical Class" for the 2010 pharmaceutical engineering major to realize the integration of production, education and research.
To build the first brand of domestic anti-tumor implant series products
In September 2010, Suzhou Huayuan Pharmaceutical Co., Ltd. jointly invested in the establishment of "Anhui Fengyuan Suzhou Pharmaceutical Technology Co., Ltd."; and Anhui Zhongren Technology Co., Ltd. jointly invested in the establishment of "Anhui Fengyuan Zhongren Pharmaceutical Co., Ltd." to build a domestic The first brand of anti-tumor implant series products.
Strategic cooperation with Chinese Heart Rhythm Society
In April 2009, strategically cooperated with the Chinese Heart Rhythm Society, and held the launch meeting of the project "Clinical Application of Ibutilite Converting Atrial Fibrillation and Atrial Flutter".
Expand the international pharmaceutical market
In December 2008, "Anhui Fengyuan Pharmaceutical Import and Export Co., Ltd." was established to expand the international pharmaceutical market.
86-0551-64846100
127841476@qq.com
CopyRight © 2022 Anhui BBCA Pharmaceuticals Co., Ltd Powered by：www.300.cn SEO
448022937@qq.com
+182619958320
+0551-64846105